Vitamin D deficiency: A review of the relationship between vitamin Deficiencies somedisease as Obesity, Diabetes and Cardiovascular in Al-Muthanna Province - Iraq

Authors

  • Hanaa Ali Aziz College of Science, Al-Muthanna University, Iraq Author
  • Dhay Ali Azeez College of Science, Al-Muthanna University, Iraq Author

DOI:

https://doi.org/10.61841/ax344a94

Keywords:

Vitamin D, Obesity, Diabetes, Cardiovascular

Abstract

Vitamin D deficiency is pandemic, and has been implicated in a wide variety of disease such obesity, diabetes and cardiovascular. Recent studies have found a relationship between vitamin D deficiency and an increase in the weight of people, it showed the presence of an enzyme responsible for the formation of vitamin D and the efficacy of metabolism , The lower action of this enzyme leads to a lack of vitamins and hence the low level of metabolic activity in people.Vitamin D deficiency predisposes individuals to type 1 and type 2 diabetes, and receptors for its activated form 1α,25-dihydroxyvitamin D3 have been identified in both beta cells and immune cells. The researchers shown role in the development of type 2 diabetes through impair insulin synthesis and secretion in humans andanimal models. Also , epidemiological studies suggest a link between vitamin D deficiency in early life and the later onset of type 1 diabetes. Also, several studies have reported that vitamin D deficiency is associated with increased risk of cardiovascular disease, including hypertension, heart failure and ischemic heart disease.

 

Downloads

Download data is not yet available.

References

1- Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymalmultipotent cells. J Endocrinol Feb;(2009) 200(2): 207–21. [PubMed: 19036760]

2- Arunabh, S.; Pollack, S.; Yeh, J.; Aloia, J.F. Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab. (2003), 88, 157–161.

3- Bouillon R, Verstuyf A, Verlinden L, Eelen G, Mathieu C (2003) Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. Recent Results Cancer Res 164:353–356.

4- Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J ClinNutr 79:820–825.

5- Dawson-Hughes, B(2008).Treatment of Vitamin D Deficient States. In: Up To Date, Basow, DS (Ed). Up To Date, Waltham, MA.

6- Fronczak CM, Baron AE, Chase HP et al (2003) In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 26:3237–3242.

7- Giulietti A, Gysemans C, Stoffels K et al (2004) Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia47:451–462.

8- Goodpaster, B.; Krishnaswami, S.; Harris, T.; Katsiaras, A.; Kritchevsky, S.; Simonsick, E.; Nevitt, M.; Holvoet, P.; Newman, A. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Int. Med.( 2005), 165, 777–783.

9- Holick, M. (2006). High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo ClinProc; 81 (3):353-373.

10- Holick MF (2003) Vitamin D: a millenium perspective. J Cell Biochem88:296–307. 11-hydroxyvitamin D in overweight or obese women. Obesity (2012), 20, 2296–2301.

12- Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet 358:1500–1503.

13- Isaia G, Giorgino R, Adami S (2001) High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 24:1496.

14- Kong, J.; Li, Y.C. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3t3-l1 cells. Am. J. Physiol. Endocrinol. Metab. (2006), 290, E916–E924.

15- Lagunova, Z.; Porojnicu, A.; Lindberg, F.; Hexeberg, S.; Moan, J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. (2009), 29, 3713–3720.

16- Lementowski, P.; Zelicof, S. Obesity and osteoarthritis. Am. J. Orthop. (2008), 37, 148–151.

17- Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest Jul;(2002) 110(2):229–38. [PubMed: 12122115].18-London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F. Mineral metabolism and arterial functions in end- stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am SocNephrolFeb;(2007) 18(2):613–20. [PubMed: 17202417].

19- Mathieu C, Van Etten E, Decallonne B et al (2004) Vitamin D and 1,25-dihydroxyvitamin D(3) as modulators in the immune system. J Steroid BiochemMolBiol 89–90:449–452.

20- Mathieu C, Van Etten E, Gysemans C, Decallonne B, Bouillon R (2002) Seasonality of birth in patients with type 1 diabetes. Lancet 359:1248.

21- Motohashi Y, Yamada S, Yanagawa T et al (2003) Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J ClinEndocrinolMetab88:3137–3140.

22- Nejentsev S, Cooper JD, Godfrey L et al (2004) Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 53:2709–2712.

23- Noncommunicable Diseases Country Profiles; World Health Organisation: Geneva, Switzerland, (2011); p. 209.

24- Oh JY, Barrett-Connor E (2002) Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51:356–359. 25-Ortlepp JR, Metrikat J, Albrecht M, von Korff A, Hanrath P, Hoffmann R (2003) The vitamin D receptor gene variant and physicalactivitypredictsfastingglucoselevelsinhealthyyoung men. Diabet Med 20:451–454.

26- Parikh, S.J.; Edelman, M.; Uwaifo, G.I.; Freedman, R.J.; Semega-Janneh, M.; Reynolds, J.; Yanovski, J.A. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J. Clin.

Endocrinol. Metab. (2004), 89, 1196–1199.

27- Pazirandeh, S; Burns, D, Waltham, MA, (2008). Overview of Vitamin D. In: Up To Date, Basow, DS (Ed). Up To Date.

28- Pilz, S; Tomashitz, A; Eberhard, R; Pieber, T(2009). Vitamin D Status and Arterial Hypertension: A Systematic Review, Oct.

29- Pi-Sunyer, F.X. The obesity epidemic: Pathophysiology and consequences of obesity. Obes. Res. (2002), 10, 97S– 104S.

30- Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, Christakos S (2001) Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 142:3649–3655. 31-Rock, C.L.; Emond, J.A.; Flatt, S.W.; Heath, D.D.; Karanja, N.; Pakiz, B.; Sherwood, N.E.; Thomson, C.A. Weight loss is associated with increased serum.

32- Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J ClinNutr Apr;(2006) 83(4):754–9. [PubMed: 16600924].

33- Sergeev, I. 1,25-dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem. Biophys. Res. Common. (2009), 384, 18–21.

34- Stene LC, Joner G (2003) Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J ClinNutr 78:1128–1

35- Stranges, S.; Trevisan, M.; Dorn, J.; Dmochowski, J.; Donahue, R. Body fat distribution, liver enzymes, and risk of hypertension: Evidence from the western New York study. Hypertension (2005), 46, 1186–1193.

36- Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid BiochemMolBiol Mar;(2007) 103(35):521–4. [PubMed: 17275289].

37- Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med Mar;(2008)25(3):320–5. [PubMed: 18279409].

38- van Halteren AG, Van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C (2002) Redirection of human autoreactiveTcells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D3. Diabetes 51:2119– 2125.

39- Vimeswaran, K.; Berry, D.; Lu, C.; Pilz, S.; Hiraki, L.; Cooper, J.; Dastani, Z.; Li, R.; Houston, D.; Wood, A. Causal relationship between obesity and vitamin D status: Bi-directional mendelian randomization analysis of multiple cohorts. PLoS Med. (2013), 10, 1549–1676.

40- Wamberg, L.; Christiansen, T.; Paulsen, S.K.; Fisker, S.; Rask, P.; Rejnmark, L.; Richelsen, B.; Pedersen, S.B. Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss. Int. J. Obes. (2012), doi:10.1038/ijo.2012.112.

41- Zalman, S; Drezner, M. Waltham, MA, (2008). Causes of Vitamin Deficiency and Resistance. In: Up To Date

,Basow, DS (Ed). Up To Date.

42- Zella JB, McCary LC, Deluca HF (2003) Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch BiochemBiophys 417:77–80

Downloads

Published

30.11.2020

How to Cite

Aziz, H. A., & Azeez, D. A. (2020). Vitamin D deficiency: A review of the relationship between vitamin Deficiencies somedisease as Obesity, Diabetes and Cardiovascular in Al-Muthanna Province - Iraq. International Journal of Psychosocial Rehabilitation, 24(9), 4984-4989. https://doi.org/10.61841/ax344a94